
6. Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth
CM (2011) Association between time to initiation of adjuvant che-
motherapy and survival in colorectal cancer: a systematic review
and meta-analysis. JAMA 305(22):2335–2342
7. Sun Z, Adam MA, Kim J, Nussbaum DP, Benrashid E, Mantyh CR,
Migaly J (2016) Determining the optimal timing for initiation of
adjuvant chemotherapy after resection for stage II and III colon
cancer. Dis Colon rectum 59(2):87–93
8. Bos AC, van Erning FN, van Gestel YR, Creemers GJ, Punt CJ, van
Oijen MG, Lemmens VE (2015) Timing of adjuvant chemotherapy
and its relation to survival among patients with stage III colon
cancer. Eur J Cancer 51(17):2553–2561
9. Czaykowski PM, Gill S, Kennecke HF, Gordon VL, Turener D
(2011) Adjuvant chemotherapy for stage III colon cancer: does
timing matter? Dis Colon rectum 54(9):1082–1089
10. Malietzis G, Mughal A, Currie AC, Anyamene N, Kennedy RH,
Athanasiou T, Jenkins JT (2015) Factors implicated for delay of
adjuvant chemotherapy in colorectal cancer: a meta-analysis of ob-
servational studies. Ann Surg Oncol 22(12):3793–3802
11. Farrell, C, Brearley, S.G, Pilling, M, Molassiotis, A (2013) The
impact of chemotherapy-related nausea on patients’ nutritional sta-
tus, psychological distress and quality of life. Support Care Cancer
21(1):59–66
12. Krebber AM, Buffart LM, Kleijn G, Riepma IC, Bree R, Leemans
CR (2014) Prevalence of depression in cancer patients: a meta-
analysis of diagnostic interviews and self-report instruments.
Psycho Oncol 23(2):121–130
13. Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C,
Palmer N, Ream E, Young A, Richardson A (2009) Patients’ sup-
portive care needs beyond the end of cancer treatment: a prospec-
tive, longitudinal survey. J Clin Oncol 27:6172–6179
14. Oken MM, C reech RH, Tormey DC, Horton J, Davis TE,
McFadden ET, Carbone PP (1982) Toxicity and response criteria
of the Eastern Cooperative Oncology Group. Am J Clin Oncol
5(6):649–655
15. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D,
Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C,
Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M
(2009) The Clavien-Dindo classification of surgical complications:
five-year experience. Ann Surg 250(2):187–196
16. Zigmond AS, Snaith RP (1983) The hospital anxiety and depres-
sion scale. Acta Psychiatr Scand 67:361–370
17. Ye WF, Xu JM (1993) An evaluation of the hospital anxiety and
depression scale in the general hospital patients. China Acts of
Medical Sciences 2:17–19
18. Han Y, Zhou Y, Wang J, Zhao Q, Qin H, Fan Y, Song Y, Boyes A,
Cui S (2017) Psychometric testing of the Mandarin version of the
34-item Short-Form Supportive Care Needs Survey in patients with
cancer in mainland China. Support Care Cancer 25(11):3329–3338
19. Buyse M, Zeleniuch-Jacquotte A, Chalmers TC (1988) Adjuvant
therapy of colorectal cancer. Why we still don’t know. JAMA
259(24):3571–3578
20. Kim YW, Choi EH, Kim BR, Ko WA, Do YM, Kim IY (2017) The
impact of delayed commencement of adjuvant chemotherapy (eight
or more weeks) on survival in stage II and III colon cancer: a
national population-based cohort study. Oncotarget 8(4):1–12
21. Bayraktar S, Bayraktar UD, Rocha-Lima CM (2010) Timing of
adjuvant and neoadjuvant therapy in colorectal cancers. Clin
Colorectal Cancer 9(3):144–149
22. Park HS, Jung M, Kim HS, Kim HI, An JY, Cheong JH, Hyung WJ,
Noh SH, Kim YI, Chung HC, Rha SY (2015) Proper timing of
adjuvant chemotherapy affects survival in patients with stage 2
and 3 gastric cancer. Ann Surg Oncol 22(1):224–231
23. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S
(2001) The prevalence of psychological distress by cancer site.
Psychooncology 10:19–28
24. Font R, Espinas JA, Layos L, Martinez Villacampa M, Capdevila J,
Tobena M (2017) Adherence to capecitabine in preoperative treat-
ment of stage II and III rectal cancer: do we need to worry? Ann
Oncol 28:831–835
25. Garcia MA, Kalecinski J, Oriol M, Bonne A, Lofti M, Espenel S,
Tinquaut F, Collard O, Vassal C, Rivoirard R, Regnier V, Chauvin
F, Bourmaud A (2018) Cancer patients treated with intravenous
chemotherapy for the first time. What are their needs? What do they
lack? A qualitative–quantitative mixed approach Patient Prefer
Adherence 19(12):1853–1861
26. Fiszer C, Dolbeault S, Sultan S, Brédart A (2014) Prevalence, in-
tensity, and predictors of the supportive care needs of women diag-
nosed with breast cancer: a systematic review. Psychooncology 23:
361–374
27. Akechi T, Okuyama T, Endo C (2011) Patient’s perceived need and
psychological distress and/or quality of life in ambulatory breast
cancer patients in Japan. Psychooncology 20:497–505
28. Parle M, Jones B, Maguire P (1996) Maladaptive coping and affec-
tive disorders among cancer patients. Psychol Med 26(4):735–744
29. Ford S, Lewis S, Fallowfield L (1995) Psychological morbid-
ity in newly referred patients with cancer. J Psychosom Res
39(2):193–202
30. Girgis A, Breen S, Stacey F, Lecathelinais C (2009) Impact of two
supportive care interventions on anxiety, depression, quality of life,
and unmet needs in patients with nonlocalized breast and colorectal
cancers. J Clin Oncol 27:6180–6190
31. Xie FL, Wang YQ, Peng LF, Lin FY, He YL, Jiang ZQ (2017)
Beneficial effect of educational and nutritional intervention on the
nutritional status and compliance of gastric cancer patients undergo-
ing chemotherapy: a randomized trial. Nutr Cancer 69(5):762–771
32. Li Z, Wei D, Zhu C, Zhang Q (2019) Effect of a patient education
and rehabilitation program on anxiety, depression and quality of life
in muscle invasive bladder cancer patients treated with adjuvant
chemotherapy. Medicine (Baltimore) 98(44):e17437
33. Yanwei L, Minghui F, Manman Q, Zhuchu n Y, Dongying L,
Zhanyu P (2018) Influence of wellness education on first-line
icotinib hydrochloride patients with stage IV non–small cell
lung cancer and their family caregivers. C urr Probl Cancer
42(3):358–366
34. Zhang M, Chan SW, You L, Wen Y, Peng L, Liu W, Zheng M
(2014) The effectiveness of a self-efficacy-enhancing intervention
for Chinese patients with colorectal cancer: a randomized controlled
trial with 6-month follow up. Int J Nurs Stud 51(8):1083–1092
Publisher’snote Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Support Care Cancer